QOP
Quinn Opportunity Partners Portfolio holdings
AUM
$1.16B
This Quarter Return
+9.44%
1 Year Return
+30.27%
3 Year Return
+47.92%
5 Year Return
+94.34%
10 Year Return
+147.84%
AUM
$1.16B
AUM Growth
+$1.16B
(-18%)
Cap. Flow
-$344M
Cap. Flow
% of AUM
-29.59%
Top 10 Holdings %
Top 10 Hldgs %
29.06%
Holding
436
New
49
Increased
73
Reduced
86
Closed
88
Top Buys
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$13.4M |
| 2 |
Mid-America Apartment Communities
MAA
|
$11.8M |
| 3 |
PG&E
PCG
|
$11.2M |
| 4 |
Interactive Brokers
IBKR
|
$10.6M |
| 5 |
Dick's Sporting Goods
DKS
|
$9.8M |
Top Sells
| 1 |
JNPR
Juniper Networks
JNPR
|
$29.9M |
| 2 |
CVS Health
CVS
|
$22.7M |
| 3 |
Microsoft
MSFT
|
$22.4M |
| 4 |
Netflix
NFLX
|
$21M |
| 5 |
BioNTech
BNTX
|
$18.4M |
Sector Composition
| 1 | Consumer Discretionary | 26.55% |
| 2 | Communication Services | 25.13% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 6.79% |
| 5 | Consumer Staples | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESGR
151
DELISTED
Enstar Group
ESGR
| $1.5M | 0.13% |
4,458
-11,628
| -72% | -$3.91M |
|
152
CureVac
CVAC
$1.21B
| $1.47M | 0.12% |
270,911
+204,073
| +305% | +$1.11M |
|
|
DHC
153
Diversified Healthcare Trust
DHC
$920M
| $1.47M | 0.12% |
409,660
-5,000
| -1% | -$17.9K |
|
154
Yelp
YELP
$1.99B
| $1.44M | 0.12% |
42,133
-5,000
| -11% | -$171K |
|
155
Arbutus Biopharma
ABUS
$711M
| $1.44M | 0.12% |
464,513
| – | – |
|
156
AMC Networks
AMCX
$306M
| $1.42M | 0.12% |
226,051
| – | – |
|
157
Janux Therapeutics
JANX
$1.37B
| $1.38M | 0.12% |
59,893
+8,000
| +15% | +$185K |
|
158
Evolent Health
EVH
$1.12B
| $1.35M | 0.11% |
120,000
| – | – |
|
159
Bumble
BMBL
$642M
| $1.32M | 0.11% |
200,372
+149,372
| +293% | +$984K |
|
160
Everest Group
EG
$14.3B
| $1.32M | 0.11% |
3,872
| – | – |
|
161
PENN Entertainment
PENN
$2.95B
| $1.26M | 0.11% |
70,340
| – | – |
|
162
The Mosaic Company
MOS
$10.6B
| $1.24M | 0.1% |
34,040
| – | – |
|
|
FLG
163
Flagstar Financial, Inc.
FLG
$5.33B
| $1.24M | 0.1% |
116,666
-80,000
| -41% | -$848K |
|
164
FIVE9
FIVN
$2.08B
| $1.22M | 0.1% |
46,000
| – | – |
|
165
Thermo Fisher Scientific
TMO
$186B
| $1.22M | 0.1% |
+3,000
| New | +$1.22M |
|
166
Algoma Steel
ASTL
$511M
| $1.21M | 0.1% |
176,342
-20,000
| -10% | -$138K |
|
167
Novavax
NVAX
$1.21B
| $1.2M | 0.1% |
190,118
+74,057
| +64% | +$467K |
|
|
PGRE
168
Paramount Group
PGRE
$1.59B
| $1.19M | 0.1% |
194,400
+110,000
| +130% | +$671K |
|
169
Citigroup
C
$178B
| $1.14M | 0.1% |
13,401
+3,422
| +34% | +$291K |
|
170
United Parks & Resorts
PRKS
$2.89B
| $1.13M | 0.09% |
24,000
+9,000
| +60% | +$424K |
|
171
Fidelity National Information Services
FIS
$36.5B
| $1.13M | 0.09% |
13,883
-544
| -4% | -$44.3K |
|
172
DigitalBridge
DBRG
$2.08B
| $1.13M | 0.09% |
109,166
| – | – |
|
173
SPDR S&P Biotech ETF
XBI
$5.07B
| $1.12M | 0.09% |
+13,500
| New | +$1.12M |
|
174
Invesco
IVZ
$9.76B
| $1.11M | 0.09% |
+70,100
| New | +$1.11M |
|
175
Iovance Biotherapeutics
IOVA
$807M
| $1.06M | 0.09% |
+614,200
| New | +$1.06M |
|